View Older Stories View More Recent Stories

Sep 15, 2025 04:07PM Alex M. Azar II Joins Guardant Health Board of Directors
Sep 11, 2025 08:05AM Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
Sep 8, 2025 08:05AM Guardant Health partners with PathGroup to expand Shield blood test access
Sep 8, 2025 08:05AM Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
Sep 4, 2025 08:07AM Guardant Health reports improved Shield cancer test performance
Sep 4, 2025 08:06AM Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
Aug 28, 2025 04:05PM Guardant Health to Host Investor Day on September 24, 2025
Aug 26, 2025 04:05PM Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Aug 15, 2025 05:05PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 4, 2025 08:06AM American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
Jul 31, 2025 04:05PM Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 30, 2025 04:05PM Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Jul 30, 2025 08:09AM Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
Jul 29, 2025 08:07AM New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
Jul 15, 2025 11:01AM First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
Jul 14, 2025 08:00AM Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025
Jun 10, 2025 07:05AM Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening
Jun 9, 2025 08:05AM New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer
Jun 3, 2025 08:05AM Guardant Health (GH) Granted FDA Breakthrough Device Designation for Multi-Cancer Detection (MCD) Test
Jun 3, 2025 08:05AM FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test
Jun 2, 2025 08:05AM National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening
Jun 2, 2025 07:00AM SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advan
May 31, 2025 08:05AM In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Ti
May 27, 2025 05:32PM Guardant Health (GH) announces new features for Guardant 360 Liquid test
May 27, 2025 05:30PM Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test
May 22, 2025 05:05PM Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting
May 21, 2025 08:05AM Guardant Health (GH) adds full suite of IHC testing
May 21, 2025 08:05AM Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors
May 20, 2025 08:09AM Guardant Health (GH) Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
May 20, 2025 08:05AM Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
May 8, 2025 04:05PM Guardant Health to Participate in Upcoming Investor Conferences
May 8, 2025 09:20AM TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year
May 7, 2025 05:05PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 30, 2025 04:05PM Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Apr 29, 2025 04:20PM Guardant Health (GH) Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
Apr 29, 2025 04:20PM Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
Apr 28, 2025 08:06AM Guardant Health (GH) Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
Apr 28, 2025 08:05AM Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
Apr 24, 2025 08:05AM Guardant Health (GH) Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
Apr 24, 2025 08:05AM Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
Apr 22, 2025 08:05AM Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR
Apr 10, 2025 04:05PM Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025
Apr 3, 2025 08:08AM Guardant Health (GH) partners with Bayshore HealthCare to offer testing portfolio in Canada
Apr 3, 2025 08:05AM Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
Mar 25, 2025 04:09PM Guardant Health's (GH) Shield Blood Test Now Covered for VA Community Care Beneficiaries
Mar 25, 2025 04:05PM Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries
Mar 11, 2025 07:02AM Guardant Health (GH) Receives ADLT Status From CMS for Shield Blood Test
Mar 11, 2025 07:00AM Guardant Health Receives ADLT Status From CMS for Shield Blood Test
Mar 5, 2025 08:05AM Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities
Feb 28, 2025 05:05PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View More Recent Stories View Older Stories